tiprankstipranks
Trending News
More News >

Vimta Labs Releases Audited Financial Results for FY 2024-25

Story Highlights
  • Vimta Labs provides analytical and research services in the life sciences sector.
  • The company announced its audited financial results for FY 2024-25, reinforcing transparency and compliance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Vimta Labs Limited ( (IN:VIMTALABS) ) just unveiled an announcement.

Vimta Labs Limited announced the approval of its audited financial results for the fourth quarter and fiscal year ending March 31, 2025. The financial statements were endorsed by the board of directors following recommendations from the audit committee. These results, which received an unmodified opinion, have been made available on the company’s website and the websites of the BSE and NSE. This announcement underscores Vimta Labs’ transparency and adherence to regulatory requirements, potentially reinforcing stakeholder confidence and supporting its market position.

More about Vimta Labs Limited

Vimta Labs Limited operates in the life sciences sector, providing a range of analytical, testing, and research services. The company is driven by a commitment to quality and scientific innovation, focusing on delivering comprehensive solutions to its clients in various industries.

YTD Price Performance: 3.16%

Average Trading Volume: 16,532

Current Market Cap: 22.7B INR

For a thorough assessment of VIMTALABS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App